VERALEC Trademark

Trademark Overview

On Friday, July 26, 2013, a trademark application was filed for VERALEC with the United States Patent and Trademark Office. The USPTO has given the VERALEC trademark a serial number of 86020784. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 18, 2025. This trademark is owned by Angiocrine Bioscience. The VERALEC trademark is filed in the Chemical Products category with the following description:

Cell growth media for growing cells for use in scientific research; Cells for scientific, laboratory or medical research

General Information

Serial Number86020784
Word MarkVERALEC
Filing DateFriday, July 26, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 18, 2025
Registration Number4618512
Registration DateTuesday, October 7, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2013

Trademark Statements

Translation of Words in MarkThe wording "VeraLec" has no meaning in a foreign language.
Goods and ServicesCell growth media for growing cells for use in scientific research; Cells for scientific, laboratory or medical research

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 18, 2025
Primary Code001
First Use Anywhere DateFriday, March 1, 2013
First Use In Commerce DateFriday, March 1, 2013

Trademark Owner History

Party NameAngiocrine Bioscience
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameAngiocrine Bioscience
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10065
Party NameAngiocrine Bioscience
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10065

Trademark Events

Event DateEvent Description
Friday, November 8, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 30, 2013NEW APPLICATION ENTERED
Wednesday, July 31, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 8, 2013ASSIGNED TO EXAMINER
Wednesday, November 27, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 17, 2013PUBLISHED FOR OPPOSITION
Tuesday, December 17, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 11, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 8, 2014TEAS STATEMENT OF USE RECEIVED
Friday, August 8, 2014USE AMENDMENT FILED
Wednesday, August 27, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 3, 2014STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 4, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 5, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 7, 2014REGISTERED-PRINCIPAL REGISTER
Wednesday, May 11, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 11, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 7, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, December 9, 2019TEAS SECTION 8 RECEIVED
Monday, December 9, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 29, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 29, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 15, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, January 15, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED
Wednesday, January 15, 2020NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Friday, July 29, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, October 7, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, April 18, 2025CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Related Keywords

veralec research scientific cells laboratory medical growth media cell growing